Aricept helps moderate to severe Alzheimer's too
Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's doing any good, a new study says.
The study of Aricept also found some benefit if the patient switches to another frequently used drug, Namenda. But it found that combining the two drugs, a common strategy in the United States, was not significantly more effective than using Aricept alone.
That last finding conflicts with an earlier study, and experts said it would probably not change what most doctors do in the United States.
The overall study results generally provide statistical support for what most doctors recommend, said Dr. Ronald Petersen of the Mayo Clinic, a member of the Alzheimer's Association board of directors. He didn't participate in the research.
More than 5 million Americans have Alzheimer's, according to the association. The progressive disorder impairs memory, judgment and other mental abilities. Treatments can only ease symptoms rather than reverse a patient's overall decline.
The new research is reported in Thursday's issue of the New England Journal of Medicine by scientists in the United Kingdom. It involved 295 patients who had moderate or severe Alzheimer's and had been taking Aricept, also known as donepezil, for at least three months.
The patients were randomly assigned to continue on Aricept, switch to Namenda, take both, or take only placebo pills. Then they were followed for a year and tested on mental prowess and ability to carry out daily activities.
Results showed that continuing on Aricept gave a modest benefit over taking no drug, while switching to Namenda, also called memantine, provided a lesser one. While an analysis found no evidence that combining the drugs gave a significant benefit over just continuing Aricept, it may have included too few patients to demonstrate a difference, said Dr. Robert Howard of the Institute of Psychiatry at King's College London, who led the research.
A separate analysis indicated each drug provided an independent benefit, Howard said, so he still recommends combining them if possible in moderate to severe Alzheimer's.
The work was financed by the U.K. Medical Research Council and Britain's Alzheimer's Society. Drugs were supplied by Pfizer Inc., Eisa Inc. and Lundbeck UK. Several authors reported having received lecture fees or other payments from those companies.
More information: New England Journal of medicine: http://www.nejm.org
©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- FDA approves larger dose of Pfizer's Aricept Jul 25, 2010 | not rated yet | 0
- Commonly used dementia drugs can help more patients with Alzheimer's Mar 07, 2012 | not rated yet | 0
- High doses of Alzheimer's drug Aricept should be banned, Public Citizen says May 19, 2011 | not rated yet | 0
- UCLA imaging study suggests Alzheimer's drug may help mild memory loss Jul 30, 2008 | not rated yet | 0
- Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease Apr 11, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
6 hours ago Alright, so in Pathfinder (like Dungeons and Dragons) there's a spell that allows you to lift/move stuff within 25 ft with 5 pounds of force. A...
8 hours ago So energy can only be converted... So when you squeeze the bulb on a blood pressure cuff, you are applying kinetic energy. Then the cuff fills with...
How does momentum, inertia and drag affect the motion of an object?
11 hours ago How does momentum and inertia affect changes in speed, when considering acceleration from thrust, or from decelleration from drag? Say, for a...
What is Time-Varying Voltage?
12 hours ago In circuits, we have no problem saying that the voltage difference between two point is [itex]\cos(\omega t)[/itex], but what does that actually...
Contextual Relationships Between Momentum, Energy, and Force.
14 hours ago *I apologize in advance for the length of this post, if you wish to reduce reading skip to paragraph 5. Or if you are super lazy, the final...
Barometric pressure and the math behind it. Very interesting, I think.
15 hours ago Hey guys, I was actually researching the life of Edmond Halley and discovered that he discovered the relationship between barometric pressure and the...
- More from Physics Forums - Classical Physics
More news stories
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
Alzheimer's disease & dementia 17 hours ago | 5 / 5 (2) | 0 |
(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.
Alzheimer's disease & dementia May 16, 2013 | 5 / 5 (1) | 0
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The li ...
Alzheimer's disease & dementia May 15, 2013 | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have helped identify many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder ...
Alzheimer's disease & dementia May 14, 2013 | 3 / 5 (1) | 0 |
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, ...
Alzheimer's disease & dementia May 13, 2013 | 4.2 / 5 (5) | 0 |
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
7 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
8 hours ago | not rated yet | 0 |
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
20 hours ago | 3.7 / 5 (3) | 0 |
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
19 hours ago | not rated yet | 0 |
(AP)—Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday.
May 17, 2013 | 5 / 5 (1) | 3
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
17 hours ago | 3.7 / 5 (3) | 0 |